This inventor holds 1 USPTO granted patent and 6 published patent applications and 2 EPO patents. Top assignee: The Rockefeller University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: David John Huggins: Innovator in Pharmaceutical Research
Introduction: David John Huggins is an accomplished inventor based in New York, NY (US). He is currently affiliated with The Rockefeller University, where he contributes to advancements in pharmaceutical research. Although he has not yet been granted any patents, his work is focused on developing innovative compounds for medical applications.
Latest Patent Applications: David John Huggins has submitted several notable patent applications. One of his latest applications is titled "C-Linked Inhibitors of ENL/AF9 YEATS." This application discloses compounds of Formula I and pharmaceutical compositions that include these compounds. It also outlines methods for treating acute leukemias using these innovative compounds. Another significant application is "Pyrrolopyridine-3- and 4-Carboxamide Compositions and Methods for Cellular Proliferation." This application details N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides and related compounds, emphasizing their potential in cellular proliferation.
Conclusion: David John Huggins is a promising inventor whose research at The Rockefeller University aims to make significant contributions to the field of pharmaceuticals. His latest patent applications reflect his commitment to developing innovative solutions for medical challenges.